Ascentage Pharma Group Intl ADR (AAPG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Sales | 134,348 | 30,546 | 31,166 |
| Cost of Goods | 3,984 | 4,203 | N/A |
| Gross Profit | 130,364 | 26,343 | 31,166 |
| Operating Expenses | 176,629 | 141,842 | 0 |
| Operating Income | -45,281 | -115,296 | 31,166 |
| Interest Expense | 8,830 | 13,218 | 0 |
| Other Income | -38 | 148 | 0 |
| Pre-tax Income | -54,149 | -128,366 | 31,166 |
| Income Tax | 1,428 | -984 | N/A |
| Net Income Continuous | -55,577 | -127,382 | -131,216 |
| Minority Interests | -34 | -10 | N/A |
| Net Income | $-55,543 | $-127,372 | $-131,216 |
| EPS Basic Total Ops | -0.72 | -1.80 | -1.99 |
| EPS Basic Continuous Ops | -0.74 | -1.80 | -1.99 |
| EPS Diluted Total Ops | -0.72 | -1.80 | -1.99 |
| EPS Diluted Continuous Ops | -0.74 | -1.80 | -1.99 |
| EPS Diluted Before Non-Recurring Items | -0.72 | -1.86 | -1.99 |
| EBITDA(a) | $-34,042 | $-104,072 | $31,166 |